Clinical Pharmacology and Pharmacy of Antimicrobial Agents

doi:10.3390/books978-3-0365-9108-7

Download Url(s)

https://mdpi.com/books/pdfview/book/8291

Contributor(s)

Kovács, Dóra (editor)

Language

English

Show full item record

Abstract

In this Special Issue, our aim was to collect studies on clinical pharmacology and pharmacy of antimicrobial agents from both human and veterinary medicine as the complex problem of AMR requires actions taken within the One Health approach that involve both fields. Studies covered here are about new or optimized usage of already authorized antimicrobials, as well as discoveries about new agents, new combinations of drugs, and drug repositioning. Pharmacodynamic, pharmacokinetic, and toxicological aspects of individual and combinational drug use are areas covered in this Special Issue.

URI

https://directory.doabooks.org/handle/20.500.12854/128823

Keywords

antibiotic combination; minimum inhibitory concentration; Monte Carlo; synergistic effect; antibiotics; combination therapy; multi-drug resistant infection; meta-analysis; pan-genome; Campylobacter ureolyticus; UDP-3-O-acyl-N-acetylglucosamine deacetylase; LpxC; campylobacteriosis; self-medication; students; habits; cystic fibrosis; P. aeruginosa; transporters; Escherichia coli; suture; antimicrobial; pharmacodynamics; triclosan; surgical site infection; time-kill; contact killing; translational modelling; antifungals; adverse drug reaction (ADR); drug-drug interaction (DDI); polypharmacy; multimorbidity; intensive care patients; traumatology; elderly patients; organ failure; multi-organ failure; drug safety; patient safety; nonlinear mixed-effects modeling; glomerular filtration rate; dosing regimen; oxacillin; Monte Carlo simulations; adsorption; desorption; doxycycline; pH dependence; small ruminant feed; heterocyclic compounds; phenolic compounds; pyran; food microbiology; microbial pathogen; serum/plasma concentrations; interstitial concentrations; tissue concentrations; pharmacokinetics; macrolide antibiotics